These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 12966627)

  • 1. [On-demand treatment with gastric acid inhibitors for gastroesophageal reflux disease].
    Lamers CB
    Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1630-2. PubMed ID: 12966627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [As-needed treatment with gastric acid inhibitors in gastroesophageal reflux disease].
    Poen AC; Otten MH
    Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1632-6. PubMed ID: 12966628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of gastroesophageal reflux disease.
    Pettit M
    Pharm World Sci; 2005 Dec; 27(6):432-5. PubMed ID: 16341949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On-demand and intermittent therapy for gastro-oesophageal reflux disease: economic considerations.
    Inadomi JM
    Pharmacoeconomics; 2002; 20(9):565-76. PubMed ID: 12141885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyspepsia and reflux in primary care: rough DIAMOND of a trial.
    van Zanten SV
    Lancet; 2009 Jan; 373(9659):187-8. PubMed ID: 19150689
    [No Abstract]   [Full Text] [Related]  

  • 7. On-demand therapy for gastro-oesophageal reflux disease.
    Bytzer P
    Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S19-22. PubMed ID: 11430504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic approaches to reflux disease, focusing on acid secretion.
    Kinoshita Y; Adachi K; Fujishiro H
    J Gastroenterol; 2003 Mar; 38 Suppl 15():13-9. PubMed ID: 12698865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical treatment of gastroesophageal reflux disease - beyond the proton pump inhibitors.
    Holloway RH; Dent J
    Dig Dis; 2000; 18(1):7-13. PubMed ID: 10729732
    [No Abstract]   [Full Text] [Related]  

  • 10. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
    Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
    Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients.
    Zacny J; Zamakhshary M; Sketris I; Veldhuyzen van Zanten S
    Aliment Pharmacol Ther; 2005 Jun; 21(11):1299-312. PubMed ID: 15932360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological management of gastro-oesophageal reflux disease.
    Klinkenberg-Knol EC; Festen HP; Meuwissen SG
    Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gastroesophageal reflux disease: pathogenetic basis of differentiated tactics of treatment].
    Tkachenko EI; Uspenskiĭ IuP; Karateev AE; Bakulin IG; Pakhomova IG
    Eksp Klin Gastroenterol; 2009; (2):104-14. PubMed ID: 19552028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease.
    Garnett WR
    Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S11-8. PubMed ID: 8097363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease.
    Storr M; Meining A; Allescher HD
    Expert Opin Pharmacother; 2001 Jul; 2(7):1099-108. PubMed ID: 11583061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep disturbances associated with gastro-oesophageal reflux disease: prevalence and impact of treatment in French primary care patients.
    Cadiot G; Delaage PH; Fabry C; Soufflet C; Barthélemy P
    Dig Liver Dis; 2011 Oct; 43(10):784-7. PubMed ID: 21752736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyspepsia responsive to acid suppression therapy: reflux disease or duodenal hypersensitivity?
    Smout AJ
    Dig Liver Dis; 2000 Dec; 32 Suppl 3():S258-60. PubMed ID: 11245313
    [No Abstract]   [Full Text] [Related]  

  • 18. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the management of gastro-oesophageal reflux disease.
    Lee JM; O'Morain CA
    Postgrad Med J; 1998 Mar; 74(869):145-50. PubMed ID: 9640439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for high-dose H2-receptor blockade in the treatment of gastro-oesophageal reflux disease.
    Castell DO
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():59-67. PubMed ID: 1679673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.